Entry into a Material Definitive Agreement. Standby Equity Purchase Agreement On July 1, 2026, OneMedNet Corporation, a Delaware corporation (“the Company”) entered into a standby equity purchase agreement (the “SEPA”) with YA II PN, Ltd., a Cayman Islands exempt limited partnership (“Yorkville”). Pursuant to the SEPA, subject to certain conditions, the Company has the option to sell to Yorkville an aggregate amount of up to up to $25 million of the Company’s shares of Common Stock, par value…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 14, 2026, OneMedNet Corporation (the “Company”) received notice (the “Notice”) from the staff of the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company, based on the closing bid price of the Company’s common stock for the last 30 consecutive business days, is not in compliance with the $1.00 minimum bid price re…

Director — Jair Clarke: Mr. Clarke will not stand for re-election to the Board at the Company’s 2025 Annual Meeting of Stockholders.

Unregistered Sales of Equity Securities. The disclosures in

Entry into a Material Definitive Agreement. Private Placement Investments On June 19, 2025, OneMedNet Corporation (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with an accredited investor (the “Investor”) for the issuance and sale in a private placement (the “Private Placement”) of (i) 3,390,923 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), and (ii) pre-funded warrants to acquire 2,561,457 additiona…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 10, 2025, OneMedNet Corporation (the “Company”) received notice (the “Notice”) from the staff of the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company, based on the closing bid price of the Company’s common stock for the last 30 consecutive business days, is not in compliance with the $1.00 minimum bid price re…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On March 12, 2025, OneMedNet Corporation (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the 31 consecutive business days prior to the date of the Notice, the Company’s Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for co…

Class III Director and Audit Committee Member — Dr. Kenneth Alleyne: The Board appointed Dr. Kenneth Alleyne as a new Class III Director and member of the Audit Committee.

Chief Financial Officer (CFO) — Robert Golden: Mr. Robert Golden was promoted from interim CFO to permanent CFO with additional compensation.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 21, 2024, OneMedNet Corporation (the “Company”) received an expected delinquency notification letter (the “Notice”) from the Listing Qualifications Department staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), which indicated that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024 (the “New Del…

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review. On November 4, 2024, the Audit Committee (the “Audit Committee”) of OneMedNet Corporation (the “Company”) resolved that the Company’s previously issued financial statements (the “Prior Financial Statements”) contained within its Annual Report on Form 10-K for the year ended December 31, 2023, originally filed on April 9, 2024, should no longer be relied upon due to errors in the Prior…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On October 16, 2024, OneMedNet Corporation (the “Company”) received a letter (the “Letter”) from the staff at The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the 30 consecutive business days prior to the date of the Letter, the Company’s Common Stock, $0.0001 par value per share (the “Common Stock”), did not meet the minimum bid price of $1.00 per share required for cont…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On October 8, 2024, OneMedNet Corporation (the “Company”) received a letter (the “Letter”) from the staff at The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the 30 consecutive business days prior to the date of the Letter, the Company’s Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued listing on The Nasdaq Capital Mar…

Director — Paul Casey and Erkan Akyuz: Two directors resigned, but the company elected two new independent directors to fill the vacancies.

Entry into a Material Definitive Agreement. Securities Purchase Agreement On September 24, 2024, OneMedNet Corporation, a Delaware corporation (“the Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with an institutional investor (the “Investor”) in connection with the private placement of its common stock, warrants and pre-funded warrants (the “Private Placement”) with aggregate gross proceeds of approximately $1.7 million, before deducting fees and…

Regulation FD Disclosure. On September 26, 2024, the Company issued a press release announcing the Private Placement. A copy of this press release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference. The information in this Item 7.01, including Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), nor otherwise subject to the liabilities of that s…

Unregistered Sales of Equity Securities. The disclosure contained in

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 9, 2024, OneMedNet Corporation (the “Company”) received an expected delinquency notification letter (the “First Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”), which indicated that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024 (the “Form 10-Q”) by the applica…

Chief Financial Officer (CFO) — Lisa Embree: The CFO departed from the company.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 15, 2024, OneMedNet Corporation (the “Company”) received approval from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) to list its common stock (the “Common Stock”) and warrants (the “Warrants”) on The Nasdaq Capital Market. The Common Stock and Warrants will be transferred from The Nasdaq Global Market to The Nasdaq Capital Market at the openin…

Director — Dr. Julianne (Sun Joo) Huh: Dr. Julianne (Sun Joo) Huh resigned from the Board of Directors.

Entry into a Material Definitive Agreement. Securities Purchase Agreements On July 23, 2024 and July 25, 2024, OneMedNet Corporation, a Delaware corporation (“the Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with certain institutional investors in connection with the private placement of its common stock and pre-funded warrants (the “Private Placements”) with aggregate gross proceeds of approximately $4.6 million, before deducting fees and expen…

Unregistered Sales of Equity Securities. The disclosure contained in

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On June 20, 2024, OneMedNet Corporation (the “Company”) received an expected delinquency notification letter (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”), which indicated that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the “Form 10-Q”) by the applicable due d…

Entry into a Material Definitive Agreement. Standby Equity Purchase Agreement On June 17, 2024, OneMedNet Corporation, a Delaware corporation (“the Company”) entered into a standby equity purchase agreement (the “SEPA”) with YA II PN, LTD, a Cayman Islands exempt limited partnership managed by Yorkville Advisors Global, LP (“Yorkville”). Pursuant to the SEPA, subject to certain conditions, the Company has the option to sell to Yorkville an aggregate amount of up to up to $25 million of the Co…